A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency

Secondary antibody deficiency (SAD) is a common complication in chronic lymphocytic leukemia (CLL) which favors the development of life-threatening infections. Subcutaneous immunoglobulins (IG) (SCIG) have been proven to be as effective as intravenous immunoglobulin (IVIG) in primary immunodeficienc...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-12-01
Colecção:	Current Oncology
Assuntos:	secondary immunodeficiency intravenous immunoglobulin subcutaneous immunoglobulin chronic lymphocytic leukemia replacement therapy
Acesso em linha:	https://www.mdpi.com/1718-7729/30/1/22
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!